semaglutide alcohol use disorder addiction clinical trials Just Changed the Math on — and Every Trial Sponsor Should Be SELECT Trial – GLP-1 medications: The next big

Zepbound Data as Reported by Lilly The manufacturers language on the weight loss indication reads thus: Zepbound is indicated in combination with a reduced-calorie diet and increased physical activity: to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition. At 72 weeks, patients taking Zepbound 15mg lost an average of 20.9% of their body weight

Safety: NAC is well tolerated in both short- and long-term studies (NIH)

How Much Protein Do You Actually Need and How Big Is Your Gap

doi: 10.3390/ph17010130 31 AllenCD

Fibre : GLP-1 medications slow gastric emptying, which can lead to constipation for some users

Catania A